Skip to content

Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning

Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04543266
Enrollment
500
Registered
2020-09-10
Start date
2020-09-07
Completion date
2023-12-31
Last updated
2020-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Squamous Cell Carcinoma

Keywords

OSCC; Oral cancer; Machine Learning

Brief summary

Application Management Team: PI - Siu Wai Choi; email - htswchoi@hku.hk Delegates - Chui Shan Chu; email: sunshine.c@connect.hku.hk FollowUpUsers - Chui Shan Chu; email:sunshine.c@connect.hku.hk

Detailed description

Eligibility Criteria: \- patients were diagnosed with a baseline disease of oral squamous carcinoma. Exclusion Criteria: \- N/A Sample size: \- \ 500 subjects Source of Data: \- The data, such as age and medical records, would be obtained from Hospital Authority Clinical Management System (HACMS) Statistical analysis: \- machine learning will be applied into analysis plan

Interventions

PROCEDURESurgery

Resection of tumors

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* patients with oral squamous carcinoma * received surgery from 1st October 2000 to 1st October 2019

Exclusion criteria

N/A

Design outcomes

Primary

MeasureTime frameDescription
The primary outcomes of the study are metastasis and recurrent diseaseBaseline of OSCCThese outcomes will be entered as the dependent variables into the machine learning model

Countries

Hong Kong

Contacts

Primary ContactSW Choi, PhD
htswchoi@hku.hk+85228590390
Backup ContactChui Shan Chu, MMedSc
sunshine.c@connect.hku.hk+85252227292

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026